|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.37 USD | -1.81% |
|
-7.47% | -13.64% |
| Capitalization | 46Cr 40Cr 37Cr 35Cr 65Cr 4.22TCr 70Cr 428.85Cr 169.1Cr 2.01TCr 174.21Cr 170.62Cr 7.34TCr | P/E ratio 2025 * |
-8.24x | P/E ratio 2026 * | -8.43x |
|---|---|---|---|---|---|
| Enterprise value | 46Cr 40Cr 37Cr 35Cr 65Cr 4.22TCr 70Cr 428.85Cr 169.1Cr 2.01TCr 174.21Cr 170.62Cr 7.34TCr | EV / Sales 2025 * |
12.5x | EV / Sales 2026 * | 21.3x |
| Free-Float |
67.89% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Assembly Biosciences, Inc.
More recommendations
More press releases
| 1 day | -1.81% | ||
| 1 week | -7.47% | ||
| Current month | -13.64% | ||
| 1 month | -9.85% | ||
| 3 months | -0.27% | ||
| 6 months | +52.18% | ||
| Current year | -13.64% |
| 1 week | 29.16 |  | 32.31 |
| 1 month | 29.16 | | 38.99 |
| Current year | 29.16 | | 34.68 |
| 1 year | 7.75 | | 39.7 |
| 3 years | 7.69 | | 39.7 |
| 5 years | 7.69 | | 84.24 |
| 10 years | 7.69 | | 808.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 50 | 01/01/2023 |
| Director of Finance/CFO | - | 05/06/2025 | |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 48 | 08/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 61 | 14/12/2017 |
Gina Consylman
BRD | Director/Board Member | 54 | 20/10/2020 |
William Ringo
CHM | Chairman | 80 | 10/02/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.53% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.81% | -7.47% | +102.69% | +55.89% | 46Cr | |
| -0.89% | +1.01% | +0.87% | +12.27% | 4.89TCr | |
| -1.49% | -1.95% | +20.43% | +7.29% | 4.05TCr | |
| -0.03% | +0.09% | +60.98% | +26.34% | 3.74TCr | |
| -0.71% | -3.69% | +20.76% | +39.59% | 3.1TCr | |
| -2.43% | +1.38% | +198.54% | +339.30% | 2.33TCr | |
| -1.16% | +2.67% | +81.09% | +167.21% | 1.72TCr | |
| Average | -1.22% | -0.94% | +69.34% | +92.55% | 2.84TCr | |
| Weighted average by Cap. | -1.03% | -0.12% | +49.58% | +69.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.73Cr 3.21Cr 2.99Cr 2.79Cr 5.19Cr 338.26Cr 5.58Cr 34Cr 14Cr 161.35Cr 14Cr 14Cr 589.17Cr | 2.18Cr 1.88Cr 1.75Cr 1.63Cr 3.04Cr 198.17Cr 3.27Cr 20Cr 7.95Cr 95Cr 8.19Cr 8.02Cr 345.17Cr |
| Net income | -3.83Cr -3.3Cr -3.07Cr -2.86Cr -5.32Cr -347.17Cr -5.73Cr -35Cr -14Cr -165.6Cr -14Cr -14Cr -604.67Cr | -5.6Cr -4.83Cr -4.49Cr -4.18Cr -7.79Cr -508.13Cr -8.38Cr -52Cr -20Cr -242.38Cr -21Cr -21Cr -885.04Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
73
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 29.37 $ | -1.81% | 1,31,370 |
| 15/26/15 | 29.91 $ | -6.65% | 82,761 |
| 14/26/14 | 32.04 $ | +1.39% | 36,352 |
| 13/26/13 | 31.60 $ | +2.17% | 67,245 |
| 12/26/12 | 30.93 $ | -2.55% | 1,00,154 |
Delayed Quote Nasdaq, January 17, 2026 at 02:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
29.37USD
Average target price
47.75USD
Spread / Average Target
+62.58%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ASMB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition